1. Home
  2. REAX vs MPLT Comparison

REAX vs MPLT Comparison

Compare REAX & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$2.74

Market Cap

792.1M

Sector

N/A

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$17.15

Market Cap

772.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REAX
MPLT
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
792.1M
772.7M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
REAX
MPLT
Price
$2.74
$17.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$5.90
$31.00
AVG Volume (30 Days)
1.6M
202.1K
Earning Date
03-04-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,813,907,000.00
N/A
Revenue This Year
$57.12
N/A
Revenue Next Year
$20.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
65.60
N/A
52 Week Low
$2.55
$12.24
52 Week High
$5.65
$21.55

Technical Indicators

Market Signals
Indicator
REAX
MPLT
Relative Strength Index (RSI) 29.49 52.88
Support Level $2.55 $17.02
Resistance Level $3.28 $18.50
Average True Range (ATR) 0.20 1.21
MACD -0.07 0.02
Stochastic Oscillator 16.27 69.26

Price Performance

Historical Comparison
REAX
MPLT

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: